Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $601.08 million. The enterprise value is $295.09 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IOVA has 333.93 million shares outstanding. The number of shares has increased by 22.47% in one year.
| Current Share Class | 333.93M |
| Shares Outstanding | 333.93M |
| Shares Change (YoY) | +22.47% |
| Shares Change (QoQ) | +5.90% |
| Owned by Insiders (%) | 8.71% |
| Owned by Institutions (%) | 65.55% |
| Float | 280.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.62 |
| Forward PS | 1.75 |
| PB Ratio | 0.80 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.18 |
| Quick Ratio | 3.51 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.85% and return on invested capital (ROIC) is -31.43%.
| Return on Equity (ROE) | -51.85% |
| Return on Assets (ROA) | -27.14% |
| Return on Invested Capital (ROIC) | -31.43% |
| Return on Capital Employed (ROCE) | -47.25% |
| Revenue Per Employee | $253,794 |
| Profits Per Employee | -$447,928 |
| Employee Count | 838 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 4.00 |
Taxes
| Income Tax | -3.26M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.78% in the last 52 weeks. The beta is 1.06, so IOVA's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -77.78% |
| 50-Day Moving Average | 2.72 |
| 200-Day Moving Average | 6.69 |
| Relative Strength Index (RSI) | 36.01 |
| Average Volume (20 Days) | 19,305,292 |
Short Selling Information
The latest short interest is 77.02 million, so 23.06% of the outstanding shares have been sold short.
| Short Interest | 77.02M |
| Short Previous Month | 74.57M |
| Short % of Shares Out | 23.06% |
| Short % of Float | 27.46% |
| Short Ratio (days to cover) | 4.54 |
Income Statement
In the last 12 months, IOVA had revenue of $212.68 million and -$375.36 million in losses. Loss per share was -$1.23.
| Revenue | 212.68M |
| Gross Profit | 46.20M |
| Operating Income | -398.78M |
| Pretax Income | n/a |
| Net Income | -375.36M |
| EBITDA | -365.02M |
| EBIT | -398.78M |
| Loss Per Share | -$1.23 |
Full Income StatementBalance Sheet
The company has $359.71 million in cash and $53.72 million in debt, giving a net cash position of $305.99 million or $0.92 per share.
| Cash & Cash Equivalents | 359.71M |
| Total Debt | 53.72M |
| Net Cash | 305.99M |
| Net Cash Per Share | $0.92 |
| Equity (Book Value) | 767.87M |
| Book Value Per Share | 2.30 |
| Working Capital | 389.96M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$334.39 million and capital expenditures -$13.11 million, giving a free cash flow of -$347.50 million.
| Operating Cash Flow | -334.39M |
| Capital Expenditures | -13.11M |
| Free Cash Flow | -347.50M |
| FCF Per Share | -$1.04 |
Full Cash Flow StatementMargins
Gross margin is 21.72%, with operating and profit margins of -187.50% and -176.49%.
| Gross Margin | 21.72% |
| Operating Margin | -187.50% |
| Pretax Margin | -178.03% |
| Profit Margin | -176.49% |
| EBITDA Margin | -171.63% |
| EBIT Margin | -187.50% |
| FCF Margin | n/a |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.47% |
| Shareholder Yield | -22.47% |
| Earnings Yield | -62.45% |
| FCF Yield | -57.81% |
Dividend DetailsAnalyst Forecast
The average price target for IOVA is $12.22, which is 578.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.22 |
| Price Target Difference | 578.89% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 55.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 0.01:1.
| Last Split Date | Sep 26, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.01:1 |
Scores
IOVA has an Altman Z-Score of 3.47 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.47 |
| Piotroski F-Score | 3 |